Mirae Asset Global Etfs Holdings Ltd. Allovir, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Allovir, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 26,032 shares of ALVR stock, worth $19,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,032Holding current value
$19,784% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALVR
# of Institutions
75Shares Held
46.5MCall Options Held
201KPut Options Held
3.1K-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$8.58 Million0.29% of portfolio
-
Octagon Capital Advisors LP New York, NY9.8MShares$7.45 Million1.63% of portfolio
-
Artal Group S.A. Luxembourg, N46.6MShares$5.01 Million0.3% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.3MShares$2.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$2.01 Million0.0% of portfolio
About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $70.7M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...